簡介:Tyrphostin AG 879是酪氨酸激酶的抑制劑,能夠抑制TrKA的磷酸化,但不能抑制TrKB 和TrKC,也是高選擇性的ErbB2激酶抑制劑。
Tyrphostin AG 879物理化學性質:
密度 |
1.1±0.1 g/cm3 |
沸點 |
432.7±55.0 °C at 760 mmHg |
熔點 |
232 °C |
分子式 |
C18H24N2OS |
分子量 |
316.461 |
閃點 |
215.5±31.5 °C |
精確質量 |
316.1609 |
PSA |
102.13 |
LogP |
4.76 |
外觀性狀 |
固體;Light yellow to Yellow to Orange powder to crystal |
蒸汽壓 |
0.0±1.1 mmHg at 25°C |
折射率 |
1.6 |
儲存條件 |
Store at -20°C |
水溶解性 |
DMSO: at 26 mg/mlsoluble |
Tyrphostin AG 879詳細介紹:
英文名稱: |
Tyrphostin AG 879 |
英文別名: |
2-Propenethioamide,3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano-, (2E)-;Tyrphostin AG 879;(E)-3-amino-2-[(3,5-ditert-butyl-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-3-sulfanylprop-2-enenitrile;AG 879;AG 879 (Tyrphostin AG 879);AG-879;2-Propenethioamide,3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano-,(2E);BMK1-D4;Lopac-T-2067;α-Cyano-(3,5-di-t-butyl-4-hydroxy)thiocinnamide;(E)-3-[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano-2-propenethioamide;TYRPHOSTIN 879;ALPHA-CYANO-(3,5-DI-T-BUTYL-4-HYDROXY)THIOCINNAMIDE;(3,5-DI-T-BUTYL-4-HYDROXYBENZYLIDENE)THIOCYANOACETAMIDE;ALPHA-CYANO-(3,5-DI-TERT-BUTYL-4-HYDROXY)THIOCINNAMAMIDE;2-CYANO-3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROP-2-ENETHIOAMIDE;(E)-2-Cyano-3-(3,5-di-tert-butyl-4-hydroxyphenyl)prop-2-enethioamide;AG879;C18H24N2OS;(2E)-2-cyano-3-(3,5-di-tert-butyl-4-hydroxyphenyl)prop-2-enethioamide;tyrphostin AG879;BiomolKI_000028;BiomolKI2_000036;Lopac0_001175;BSPBio_001398;tyrphosti |
CAS號: |
148741-30-4 |
分子式: |
C18N2OSH24 |
分子量: |
316.46 |
詳細描述 |
博飛美科提供148741-30-4,Tyrphostin AG 879,Medlife,上海現(xiàn)貨。 Medlife,致力于提供高品質、高性價比小分子化合物的產品。 Medlife小分子化合物大量庫存,提供超過2萬種的抑制劑、激動劑、拮抗劑等產品,是藥物及疾病研究的重要原料供應商。 HER2 抑制劑,AG879是酪氨酸激酶的抑制劑,能夠抑制TrKA的磷酸化,但不能抑制TrKB 和TrKC,也是高選擇性的ErbB2激酶抑制劑。 查詢關鍵詞:“148741-30-4,Tyrphostin AG 879,PC16092,Medlife,上?,F(xiàn)貨”。 |
Tyrphostin AG 879參考文獻:
[1]. Rende M et al. Role of nerve growth factor and its receptors in non-nervous cancer growth: efficacy of a tyrosine kinase inhibitor (AG879) and neutralizing antibodies antityrosine kinase receptor A and antinerve growth factor: an in-vitro and in-vivo study. Anticancer Drugs. 2006 Sep;17(8):929-41.
[2]. Zhou Y et al. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis. Cancer Res. 2006 Jan 1;66(1):404-11.
[3]. Ting AK et al. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci. 2011 Jan 5;31(1):15-25.
產品技術規(guī)格說明書由上海創(chuàng)賽科技有限公司收集整理,僅作參考使用。